Quitting smoking may slow disease progression in people with multiple sclerosis (MS) a new large real-world study has found.
Researchers found that in people who had quit smoking, disease progression...
The National Institute for Health and Care Excellence (NICE) is not recommending Ponvory (ponesimod) is made available on the NHS in England and Wales for people with active, relapsing forms of...
A new review study has found that deep brain stimulation (DBS) can reduce tremors in people with multiple sclerosis (MS), but treatment may lead to speech problems and other symptoms worsening.
DBS...
A new study has found that John Cunningham virus mutations may be an early predictor for brain infection in people receiving Tysabri for multiple sclerosis (MS).
Tysabri works by preventing immune...
Oral fesoterodine fumarate can reduce bladder pressure and improve quality of life in people with multiple sclerosis (MS)-related bladder impairments, a new study has shown.
During a three-month...
Having toxoplasmosis, which is an infection by the parasite toxoplasma gondii, may help to protect against developing multiple sclerosis (MS), according to a new review study.
Toxoplasmosis occurs...
The Pfizer-BioNTech Covid-19 vaccine does not increase the risk of relapses in people with multiple sclerosis (MS) in the two months post administration, a new study has found.
It has been...
A new study has found a link between multiple sclerosis (MS) and infection in adolescence. The researchers had previously found that pneumonia in adolescence is linked to a raised risk of MS, so they...
A new study has found that Ocrevus (ocrelizumab) slows disability progression and reduces relapse risk in people with multiple sclerosis (MS) but is also associated with higher hospitalisation risk...
People newly diagnosed with multiple sclerosis (MS) or clinically isolated syndrome (CIS) often experience a symptom ‘cluster’ that can include fatigue, pain, depression and anxiety, a new study has...
